Show simple item record

dc.contributor.authorLose, Felicity
dc.contributor.authorLawrence, Mitchell G
dc.contributor.authorSrinivasan, Srilakshmi
dc.contributor.authorO'Mara, Tracy
dc.contributor.authorMarquart, Louise
dc.contributor.authorChambers, Suzanne
dc.contributor.authorGardiner, Robert A
dc.contributor.authorAitken, Joanne F
dc.contributor.authorSpurdle, Amanda B
dc.contributor.authorBatra, Jyotsna
dc.contributor.authorClements, Judith A
dc.date.accessioned2017-05-03T13:08:09Z
dc.date.available2017-05-03T13:08:09Z
dc.date.issued2012
dc.identifier.issn1431-6730
dc.identifier.doi10.1515/hsz-2011-0268
dc.identifier.urihttp://hdl.handle.net/10072/47551
dc.description.abstractKallikrein 14 (KLK14) has been proposed as a useful prognostic marker in prostate cancer, with expression reported to be associated with tumour characteristics such as higher stage and Gleason score. KLK14 tumour expression has also shown the potential to predict prostate cancer patients at risk of disease recurrence after radical prostatectomy. The KLKs are a remarkably hormone-responsive family of genes, although detailed studies of androgen regulation of KLK14 in prostate cancer have not been undertaken to date. Using in vitro studies, we have demonstrated that unlike any other prostatic KLK genes that are strictly androgen responsive, KLK14 is more broadly expressed and inversely androgen regulated in prostate cancer cells. Given these results and evidence that KLK14 may play a role in prostate cancer prognosis, we also investigated whether common genetic variants in the KLK14 locus are associated with risk and/or aggressiveness of prostate cancer in approximately 1200 prostate cancer cases and 1300 male controls. Of 41 single nucleotide polymorphisms assessed, three were associated with higher Gleason score ( = 7): rs17728459 and rs4802765, both located upstream of KLK14 , and rs35287116, which encodes a p.Gln33Arg substitution in the KLK14 signal peptide region. Our findings provide further support for KLK14 as a marker of prognosis in prostate cancer.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.format.extent544714 bytes
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.language.isoeng
dc.publisherWalter de Gruyter
dc.publisher.placeGermany
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom403
dc.relation.ispartofpageto412
dc.relation.ispartofissue5
dc.relation.ispartofjournalBiological Chemistry
dc.relation.ispartofvolume393
dc.rights.retentionY
dc.subject.fieldofresearchBiochemistry and cell biology
dc.subject.fieldofresearchcode3101
dc.titleThe kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.rights.copyright© 2012 Walter de Gruyter & Co. KG Publishers. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.
gro.date.issued2015-04-10T00:52:24Z
gro.hasfulltextFull Text
gro.griffith.authorChambers, Suzanne K.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record